Relationship between Calreticulin Gene Mutation and JAK2/MPL Negative Myeloproliferative Neoplasms / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 1532-1534, 2015.
Artículo
en Chino
| WPRIM
| ID: wpr-272567
ABSTRACT
In 2008, WHO made the JAK2V617F gene mutation as one of the specific molecular diagnostic markers of BCR/ABL-negative myeloproliferative neoplasms (MPN). In 2013 two research teams demonstrated that whole genome sequencing technology (WGS) was used to detect calreticulin gene mutation in essential thrombocythaemia (ET) and primary myelofibrosis (PMF) patients with JAK2V617F⁻ and MPL⁻ mutations. In this review, the relationship of CALR gene mutation with MPN is briefly summarized.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Neoplasias de la Médula Ósea
/
Calreticulina
/
Janus Quinasa 2
/
Receptores de Trombopoyetina
/
Genética
/
Mutación
/
Trastornos Mieloproliferativos
Límite:
Humanos
Idioma:
Chino
Revista:
Journal of Experimental Hematology
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS